These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 25543507)
1. [Significance of chromosome 7 abnormalities in myeloid malignancies]. Shi WH; Li X; Chang CK Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1739-43. PubMed ID: 25543507 [TBL] [Abstract][Full Text] [Related]
2. The enigma of monosomy 7. Inaba T; Honda H; Matsui H Blood; 2018 Jun; 131(26):2891-2898. PubMed ID: 29615405 [TBL] [Abstract][Full Text] [Related]
3. Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7. Nagamachi A; Matsui H; Asou H; Ozaki Y; Aki D; Kanai A; Takubo K; Suda T; Nakamura T; Wolff L; Honda H; Inaba T Cancer Cell; 2013 Sep; 24(3):305-17. PubMed ID: 24029230 [TBL] [Abstract][Full Text] [Related]
4. [Association between SAMD9/SAMD9L and hematological malignancies]. Narumi S; Hasegawa T Rinsho Ketsueki; 2018; 59(11):2475-2480. PubMed ID: 30531146 [TBL] [Abstract][Full Text] [Related]
5. Delineation of multiple deleted regions in 7q in myeloid disorders. Tosi S; Scherer SW; Giudici G; Czepulkowski B; Biondi A; Kearney L Genes Chromosomes Cancer; 1999 Aug; 25(4):384-92. PubMed ID: 10398433 [TBL] [Abstract][Full Text] [Related]
6. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Le Beau MM; Espinosa R; Davis EM; Eisenbart JD; Larson RA; Green ED Blood; 1996 Sep; 88(6):1930-5. PubMed ID: 8822909 [TBL] [Abstract][Full Text] [Related]
7. Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies. Wong JC; Zhang Y; Lieuw KH; Tran MT; Forgo E; Weinfurtner K; Alzamora P; Kogan SC; Akagi K; Wolff L; Le Beau MM; Killeen N; Shannon K Blood; 2010 Jun; 115(22):4524-32. PubMed ID: 20233966 [TBL] [Abstract][Full Text] [Related]
8. CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. McNerney ME; Brown CD; Wang X; Bartom ET; Karmakar S; Bandlamudi C; Yu S; Ko J; Sandall BP; Stricker T; Anastasi J; Grossman RL; Cunningham JM; Le Beau MM; White KP Blood; 2013 Feb; 121(6):975-83. PubMed ID: 23212519 [TBL] [Abstract][Full Text] [Related]
9. Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations. Hartmann L; Haferlach C; Meggendorfer M; Kern W; Haferlach T; Stengel A Genes Chromosomes Cancer; 2019 Oct; 58(10):698-704. PubMed ID: 30994218 [TBL] [Abstract][Full Text] [Related]
10. 5G2 mutant mice model loss of a commonly deleted segment of chromosome 7q22 in myeloid malignancies. Wong JC; Weinfurtner KM; Westover T; Kim J; Lebish EJ; Del Pilar Alzamora M; Huang BJ; Walsh M; Abdelhamed S; Ma J; Klco JM; Shannon K Leukemia; 2024 May; 38(5):1182-1186. PubMed ID: 38443608 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies. González MB; Gutiérrez NC; García JL; Schoenmakers EF; Solé F; Calasanz MJ; San Miguel JF; Hernández JM Cancer Genet Cytogenet; 2004 Apr; 150(2):136-43. PubMed ID: 15066321 [TBL] [Abstract][Full Text] [Related]
12. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies. Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364 [TBL] [Abstract][Full Text] [Related]
14. Candidate gene isolation and comparative analysis of a commonly deleted segment of 7q22 implicated in myeloid malignancies. Kratz CP; Emerling BM; Donovan S; Laig-Webster M; Taylor BR; Thompson P; Jensen S; Banerjee A; Bonifas J; Makalowski W; Green ED; Le Beau MM; Shannon KM Genomics; 2001 Oct; 77(3):171-80. PubMed ID: 11597142 [TBL] [Abstract][Full Text] [Related]
15. Genomic structure of the PIK3CG gene on chromosome band 7q22 and evaluation as a candidate myeloid tumor suppressor. Kratz CP; Emerling BM; Bonifas J; Wang W; Green ED; Le Beau MM; Shannon KM Blood; 2002 Jan; 99(1):372-4. PubMed ID: 11756194 [TBL] [Abstract][Full Text] [Related]
16. MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7. van den Heuvel-Eibrink MM; Wiemer EA; de Boevere MJ; Slater RM; Smit EM; van Noesel MM; van der Holt B; Schoester M; Pieters R; Sonneveld P Leukemia; 2001 Mar; 15(3):398-405. PubMed ID: 11237063 [TBL] [Abstract][Full Text] [Related]
17. Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome. Asou H; Matsui H; Ozaki Y; Nagamachi A; Nakamura M; Aki D; Inaba T Biochem Biophys Res Commun; 2009 May; 383(2):245-51. PubMed ID: 19358830 [TBL] [Abstract][Full Text] [Related]
18. The significance of CUX1 and chromosome 7 in myeloid malignancies. Jotte MRM; McNerney ME Curr Opin Hematol; 2022 Mar; 29(2):92-102. PubMed ID: 35084368 [TBL] [Abstract][Full Text] [Related]
19. Monosomy 7 and 7q--associated with myeloid malignancy. Johnson E; Cotter FE Blood Rev; 1997 Mar; 11(1):46-55. PubMed ID: 9218106 [TBL] [Abstract][Full Text] [Related]
20. Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications. Hussain FT; Nguyen EP; Raza S; Knudson R; Pardanani A; Hanson CA; Van Dyke D; Tefferi A Am J Hematol; 2012 Jul; 87(7):684-6. PubMed ID: 22565657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]